Fwd: Orphanews Europe 10 October 2012

2 views
Skip to first unread message

José Antonio Navarro

unread,
Oct 10, 2012, 6:18:10 AM10/10/12
to
Último boletín desde OrphaNews, como siempre por si alguno de los aspectos tratados fuera de interés y recordando que solo se distribuye en inglés.
Saludos.

---------- Forwarded message ----------
From: <orphanew...@orpha.net>
Date: 2012/10/10
Subject: Orphanews Europe 10 October 2012
To: jana...@yahoo.es


OrphaNews Europe : 10 October 2012
 
Editorial
Going with the flow:
EUCERD's recommendation for improving the assessment of the Clinical Added Value of Orphan Medicinal Products encourages the creation of an Information Flow

 
EUCERD update
EUCERD gets a fresh look and updated website

 
EU Policy News
 
DG Research
Biobanks for Europe: A challenge for governance
 
EMA
Public consultation on the experience gained from five years of the Paediatric Regulation

 
National & International Policy Developments
Improving access to orphan drugs in Bulgaria and other Eastern European countries
Recommendations to improve orphan drug legislation in Europe based on the results of a Delphi policy study involving European orphan drug experts
New scheme in England allows researchers to access National Health Service patient records
European court rules that Italian law prohibiting pre-implantation diagnosis violates human rights
 
Other European news
First Wellcome Trust Pathfinder Awards encourage academic-industry collaboration for two rare diseases
 
Other International News
Pinpointing rare disease prevalence in Taiwan
 
Guidance Documents and Recommendations
Recommendations for the management of several paediatric cancers in free access
Barrett esophagus: international consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma
 
Bioinformatics, Registries and Data Management
MeSH Concepts yield more precise results for rare disease Medline information retrieval
 
Screening and Testing
Special issue of the Cancer Journal devoted to genetic testing and counselling for cancer
Integrated genome-phenome analyzer automates clinical correlation in whole genome and exome sequencing

 
New Syndromes
A novel congenital myopathy with specific biopsy features and dominant mutation of CCDC78
A 17p13.1 microdeletion syndrome inducing microcephaly, intellectual disability, distinctive facial features and body posture
Skeletal dysplasia, facial characteristics and developmental delay: a new syndrome resembling Desbuquois dysplasia
Microcephaly, intrauterine and postnatal severe growth retardation, and minimal skeletal dysplasia in two children

 
New Genes
Familial thoracic aneurysm and dissection: TGFB2 mutations induce a syndromic form occurring as part of diseases like Marfan or Loeys-Dietz syndromes
Potocki-Shaffer syndrome: translocations disrupting PHF21A are associated with intellectual disability and craniofacial anomalies
Wiedemann-Steiner syndrome: MLL haploinsufficiency disturbs epigenetic regulation of chromatin
Osteogenesis imperfecta type 5 is due to mutation in the 5’-UTR of IFITM5
Nephronophtisis-associated ciliopathy: ZNF423 and CEP164 mutations link renal ciliopathies to DNA damage response
Late-onset autosomal recessive medullary cystic kidney disease: FAN1 mutations tie chronic kidney failure to defective DNA damage repair
Weill-Marchesani syndrome: LTBP2 mutations strengthen the hypothesis of a disruption in the extracellular matrix
Colobamatous microphtalmia: a mutation in ODZ3 highlights its role in the early development of the human eye
Persistent hyperplastic primary vitreous: a mutation in ATOH7 causes a recessive form etiologically related to nonsyndromic congenital retinal nonattachment
Retinitis pigmentosa: an OFD1 mutation causes the severe form RP23 thus joining retinal ciliopathies group
Primary cutaneous diffuse large B-cell lymphoma, leg type: a specific MYD88 mutation however not present in all cases

 
Research in Action
 
Fundamental Research
Osteogenesis imperfecta types 1, 2, 3, and 4: collagen mutations impair cardiopulmonary function in a bone-independent manner
Systemic sclerosis: a mouse model mimicking the conditions responsible for pulmonary arterial hypertension
Amyotrophic lateral sclerosis: overexpressing the SMn protein in mSOD1 mice delays but does not halt the loss of motor neurons
Charcot-Marie-Tooth disease type 4J: neuronal expression of Fig4 is both necessary and sufficient to prevent spongiform neurodegeneration
Oculocerebrorenal syndrome: the localization and function of the OCRL protein suggest an involvement of the primary cilium
Autosomal dominant lateral temporal lobe epilepsy: a rat model for Lgi1-related epilepsies
Huntington disease: PGC-1α induction virtually eliminates huntingtin aggregation and ameliorates neurodegeneration in a mouse model
 
Clinical Research
Idiopathic aplastic anemia: a thrombopoietin mimetic associated with multilineage hematologic responses in some patients with refractory severe form
Graft versus host disease: inhibition of lymphocyte trafficking reduces incidence of acute visceral forms without major adverse effects
Prader-Willi syndrome: beneficial effects of GH treatment on cognitive disorders in children
Acquired hemophilia management: results from the European Acquired Haemophilia (EACH2) Registry
POEMS syndrome: autologous stem cell transplantation improves long-term outcome
Beta-thalassemia major: a safe and efficient tritherapy as preparative regimen of allogeneic hematopoietic stem cell transplantation
Idiopathic and/or familial pulmonary arterial hypertension and hyperthyroidism: a rather frequent association that should be detected early
Achondroplasia: lung function, upper airway and sleep should be regularly checked in affected children
Ataxia-telangectasia does not lead to increased risk for birth defects or adverse pregnancy outcomes other than those due to vascular lung anomalies
Bullous pemphigoid: increase of incidence during the last 15 years in France with a high standardized mortality ratio
 
Stem Cells
Congenital erythropoietic porphyria: metabolic correction obtained in erythroid cells derived from corrected induced pluripotent stem cells
Amyotrophic lateral sclerosis: motor neurons generated from patients-derived IPSc used to study the mechanisms of the disease
 
Gene Therapy
Facioscapulohumeral dystrophy: DUX4 gene silencing through RNA interference is myoprotective in a mouse model
Mucopolysaccharidosis type 7: efficiency of vectors used for gene therapy can be impacted by disease manifestations
Leigh syndrome: fatal breathing dysfunction in a mouse model with NDUFS4 inactivation, partially corrected by a gene therapy strategy
Transmissible spongiform encephalopathies: neurodegeneration is due to translational repression by eIF2α-P
 
Therapeutic Approaches
Muscle dystrophy and dilated cardiomyopathy: rapamycin and its analogs improve cardiac and skeletal muscle function in mice
Retinitis pigmentosa: restoration of visual responses in mice models after intraocular injection of a synthetic small molecule
Pelizaeus-Merzbacher disease: a cholesterol-enriched diet enhances oligodendrocyte number and function and prevents disease progression in mice
Idiopathic and/or familial pulmonary arterial hypertension: therapeutic potential of valproic acid and suberoylanilide hydroxamic acid
X-linked creatine transporter deficiency: cyclocreatine treatment improves cognitive abilities in a newly developed mouse model
 
Diagnostic Approaches
Cornelia de Lange syndrome: identification of a prenatal profile
Coffin-Siris syndrome: a diagnostic approach

 
Patient Management and Therapy
Ehlers-Danlos syndrome, hypermobility type: how to assess and treat pain and fatigue?
Intellectual disability: a digital tool to enhance diagnosis and care for rare diseases

 
Orphan Drugs
 
Regulatory News
First paediatric-specific dosage form approved for a paediatric cancer in the USA
 
Political and Scientific News
Is the special status assigned to orphan drugs justified?
Fabry disease: positive preliminary findings after switching from agalsidase beta (Fabrazyme) to agalsidase alfa (Replagal) in Japanese patients

 
Grants
Myotubular Trust issues fifth call for projects to international applicants

 
News from the Patients' Associations
When Mother knows best ...

 
Courses & Educational Initiatives
European Cytogeneticists Association Courses
Online Master of Science in Haemoglobinopathy
The European School of Haematology distance learning tools
Goldrain Courses in Clinical Cytogenetics and Prenatal Genetic Diagnosis
Orphan Academy 2012 Programme
EuroGentest Quality Management and Accreditation/Certification of Genetic Testing Workshops

 
What's on Where?
2nd Annual U.S. Conference on Rare Diseases and Orphan Products
3rd Pan-European Conference on Haemglobinopathies and Rare Anaemias: Towards the Future
The Second Joint International Symposium on Neuroacanthocytosis and Neurodegeneration with Brain Iron Accumulation
41st European Society of Clinical Pharmacy Symposium: Personalised and Safe Therapy
6th International Workshop on Alkaptonuria
International Ataxia Research Conference
8th International Society for Newborn Screening European Regional Meeting
6th International Symposium on Childhood MDS and Bone Marrow Failure syndromes
3rd Annual World Orphan Drug Congress
Translating Genomics Conference
10th Asia-Pacific Conference on Human Genetics
Symposium ATP1A3 in Disease: From Gene Mutations to New Treatments
3rd Annual World Orphan Drug Congress
First GENCODYS International Conference: Integrative Networks in Intellectual Disabilities
7th Alstrom Syndrome International Family Conference and Scientific Symposium
Autoinflammation 2013: 7th International Congress of the International Society of Systemic Auto-Inflammatory Diseases
9th European Cytogenetics Conference
8th International Prader-Willi Syndrome Conference
First International Primary Immunodeficiencies Congress (IPIC)

 
Media, Press & Publications
Three new German-language articles consider off-label drug use
 
Unsubscribe

Reply all
Reply to author
Forward
0 new messages